ConductScience.org, home

Paper17828752

ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.

Gréen H and 4 others. J Pharm Sci, 2008. Cited by 47 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel. Papers, record 17828752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17828752

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.
PubMed
Journal
J Pharm Sci
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
1.35
iCite
Revised in PubMed
2018-12-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gréen HHenrik
2Söderkvist PPeter
3Rosenberg PPer
4Horvath GGyörgy
5Peterson CCurt

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ATP Binding Cassette Transporter, Subfamily B, Member 1Major topic
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Drug Resistance, NeoplasmMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Ovarian NeoplasmsMajor topic
Polymorphism, Single NucleotideMajor topic
ATP Binding Cassette Transporter, Subfamily B
Adult
Aged
Antineoplastic Agents, Phytogenic
Carboplatin
Disease-Free Survival
Exons
Female
Gene Frequency
Genotype
Humans
Middle Aged
Paclitaxel
Patient Selection
Phenotype
Retrospective Studies
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
39913003Pharmacogenomics influence on MDR1-associated cancer resistance and innovative drug delivery approaches: advancing precision oncology.Med Oncol2025https://conductscience.org/library/papers/39913003PubMed
37686513Genetics of ABCB1 in Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/37686513PubMed
31624332ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide.Pharmacogenomics J2020https://conductscience.org/library/papers/31624332PubMed
29177954
Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.
Cancer Chemother Pharmacol2018https://conductscience.org/library/papers/29177954PubMed
29083397Effects of the ABCB1 (1199G > A) Polymorphism on Steroid Sex Hormone-Induced P-Glycoprotein Expression, ATPase Activity, and Hormone Efflux.Med Sci (Basel)2015https://conductscience.org/library/papers/29083397PubMed
25860377Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.Clin Pharmacokinet2015https://conductscience.org/library/papers/25860377PubMed
25582575Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia.Pharmacogenomics J2015https://conductscience.org/library/papers/25582575PubMed
25268163Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance.Cancers (Basel)2014https://conductscience.org/library/papers/25268163PubMed
24886434Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.BMC Cancer2014https://conductscience.org/library/papers/24886434PubMed
24586917The functional influences of common ABCB1 genetic variants on the inhibition of P-glycoprotein by Antrodia cinnamomea extracts.PLoS One2014https://conductscience.org/library/papers/24586917PubMed
24317012The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy.Acta Pharmacol Sin2014https://conductscience.org/library/papers/24317012PubMed
24019750ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro.Pharmgenomics Pers Med2013https://conductscience.org/library/papers/24019750PubMed
22437668Whole-genome studies identify solute carrier transporters in cellular susceptibility to paclitaxel.Pharmacogenet Genomics2012https://conductscience.org/library/papers/22437668PubMed
21686133Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.Int J Mol Epidemiol Genet2011https://conductscience.org/library/papers/21686133PubMed
21625253An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics.Pharmacogenomics J2011https://conductscience.org/library/papers/21625253PubMed
21396934P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.Exp Cell Res2011https://conductscience.org/library/papers/21396934PubMed
21327421Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer.Eur J Clin Pharmacol2011https://conductscience.org/library/papers/21327421PubMed
20938465Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype.Pharmacogenomics J2012https://conductscience.org/library/papers/20938465PubMed
20623213A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions.AAPS J2010https://conductscience.org/library/papers/20623213PubMed
20368717Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer.Pharmacogenomics J2011https://conductscience.org/library/papers/20368717PubMed

See all 21 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
PGP283871PubTator's text mininghttps://conductscience.org/library/genes/283871NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17828752

GET https://conductscience.org/api/papers/v1/17828752/cited_by?page=2